OriGene Technologies

Founded as a research tools company focused on the creation of genome-wide resources for gene-based research, OriGene Technologies develops and manufactures products that enable researchers to investigate gene function, protein expression and disease biology. The company is recognised for its extensive collection of full-length cDNA clones and expression-ready ORF constructs, which support applications ranging from target validation and functional genomics to biomarker discovery and drug development. By combining genomics and proteomics expertise, OriGene provides tools that help researchers study biological pathways, disease mechanisms and therapeutic targets across academic, biotechnology and pharmaceutical research.

OriGene's portfolio includes its TrueClone® and TrueORF® collections, as well as antibodies, recombinant proteins, CRISPR gene editing tools, RNAi reagents, viral gene delivery products, gene expression assays and tissue-based resources. The company has also developed proprietary antibody platforms including TrueMAB™ and UltraMAB®, supporting applications such as immunohistochemistry, flow cytometry, immunoprecipitation, ELISA and protein characterisation. These products support research workflows in cancer biology, cell biology, translational research, biomarker validation and drug discovery.

Europa Biosite subsidiaries distribute OriGene products in Austria, Belgium, Denmark, Estonia, Finland, Germany, Iceland, Ireland, Latvia, Lithuania, Luxembourg, Netherlands, Norway, Sweden, Switzerland and the United Kingdom.